Efficacy of Eribulin in Soft Tissue Sarcomas

Soft tissue sarcomas are a highly heterogenous group of tumors with limited systemic therapy options. Eribulin, a synthetic analogue of halichondrin B, is a potent mitotic inhibitor. A phase 3 trial of previously treated advanced Liposarcoma and Leiomyosarcoma demonstrated superiority of eribulin to...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Edward, Jones, Robin L., Huang, Paul, Digklia, Antonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014307/
https://www.ncbi.nlm.nih.gov/pubmed/35444542
http://dx.doi.org/10.3389/fphar.2022.869754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014307/
https://www.ncbi.nlm.nih.gov/pubmed/35444542
http://dx.doi.org/10.3389/fphar.2022.869754

Ejemplares similares